Search

everythinglearnresearchcommunity

for

Search:↓

New treatments for skin conditions related to the sebaceous gland are being developed based on current research.

Alopecia areata causes hair loss due to an immune attack on hair follicles, influenced by genetics and environment.

Some psychoactive drugs can cause skin reactions, with carbamazepine having a higher risk, and stopping the drug and seeing a dermatologist is important.

Hsc70 protein may influence hair growth by responding to androgens.

DHT affects bone growth by altering gene activity in osteoblasts, potentially complicating steroid use.

Taking 5α-reductase inhibitors with prednisolone can worsen its negative effects on metabolism.

Effective symptom management in IBD improves quality of life and prevents complications.

Free Testosterone Index, bioavailable testosterone, and androstenedione are the most accurate for diagnosing excess male hormones in PCOS.

A brain-produced steroid causes increased scratching in mice with a skin condition similar to eczema.

The document explains the difficulty in diagnosing and treating brain diseases caused by the immune system and stresses the need for quick and accurate tests.

5% minoxidil foam is a safe, effective treatment for male pattern hair loss, with increased hair count and few side effects.

Hair analysis is better than urine and blood for detecting past drug use.

The document concludes that effective acne treatment requires a personalized combination of therapies and long-term commitment, with retinoids being important for maintenance.

Female rats showed more panic-related behavior than males, influenced by hormonal cycles and certain drugs.

Chemicals and stem cells combined have advanced regenerative medicine with few safety concerns, focusing on improving techniques and treatment effectiveness.

Wound healing is complex and requires more research to enhance treatment methods.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

AGA causes hair loss by shrinking hair follicles due to DHT binding, and can be treated with finasteride and minoxidil.

High-dose dutasteride reduces PMDD symptoms by stabilizing neurosteroid levels.

The study found that two enzymes linked to hair loss are located in different parts of the scalp, supporting a common treatment's effectiveness.

Nuclear hormone receptors play a significant role in skin wound healing and could lead to better treatment methods.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

The document concludes that recognizing and properly diagnosing lipodystrophy syndromes is crucial for effective management and treatment.

Changes in skin microbes play a role in some skin diseases and could lead to new treatments.

Hormones and neuroendocrine factors control hair growth and color, and more research could lead to new hair treatment options.

Parkinson's disease is linked to skin disorders and skin cells help in studying the disease.

17α-estradiol is a safe estrogen that might protect the brain and doesn't cause feminization, needing more research for treating brain diseases.

Higher enzyme levels found in women with hair loss, suggesting hormone imbalance.

Progesterone and its byproducts control a specific receptor in the brain independently of progesterone receptors, affecting conditions related to the menstrual cycle.

XIST RNA helps regenerate hair follicles by targeting miR-424 and activating hedgehog signaling.